Anti-Leukemic Effect of Retinoic Acid in Non-APL AML Cells

被引：0
|
作者：
Harada, Yasuhiko [1 ]
Ishikawa, Yuichi [1 ]
Kawashima, Naomi [1 ]
Hattori, Hikaru [1 ]
Yamaguchi, Yohei [1 ]
Adachi, Yoshiya [1 ]
Ushijima, Yoko [2 ]
Kiyoi, Hitoshi [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Hematol & Oncol, Nagoya, Aichi, Japan
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-114298
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2805
引用
收藏
页数：3
相关论文
共 50 条
  • [1] RETINOIC ACID MIMETIC MEBENDAZOLE INDUCES RXRA TO ELICIT POTENT ANTI-LEUKEMIC EFFECT IN AML CELLS
    Illangeswaran, Raveen
    Vidhyadharan, Rakhi
    Rajamani, Bharathi
    Jebanesan, Daniel
    Charles, Chelsea
    Balasubramanian, Poonkuzhali
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [2] Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells
    Kazim, Noor
    Yen, Andrew
    CELL CYCLE, 2021, 20 (24) : 2638 - 2651
  • [3] Is there a role for differentiating therapy in non-APL AML?
    Koeffler, H. Phillip
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2010, 23 (04) : 503 - 508
  • [4] All-Trans-Retinoic Acid (ATRA) Causes Extensive Differentiation In the NPM Mutant, Non-APL Leukemic Cell Line OCI-AML3
    Kutny, Matthew A.
    Collins, Steven J.
    Loeb, Keith
    Walter, Roland B.
    Meshinchi, Soheil
    BLOOD, 2010, 116 (21) : 1354 - 1354
  • [5] RETINOIC ACID MIMETIC MEBENDAZOLE INDUCES RXRA TO ELICIT POTENT ANTI -LEUKEMIC EFFECT IN AML CELLS
    Illangeswaran, Raveen
    Vidhyadharan, Rakhi
    Rajamani, Bharathi
    Jebanesan, Daniel
    Charles, Chelsea
    Balasubramanian, Poonkuzhali
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [6] Retinoic acid receptor alpha (RARα) gene rearrangements in non-acute promyelocytic leukaemia (non-APL).
    Padua, RA
    Parrado, A
    West, R
    Jordan, D
    Bastard, C
    McKenna, S
    Whittaker, J
    Bentley, P
    Burnett, A
    Chomienne, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 39 - 39
  • [7] ALL-trans retinoic acid (ATRA) may improve results of chemotherapy in poor prognosis non-APL AML and MDS: A randomized study.
    Estey, E
    Beran, M
    Pierce, S
    Kantarjian, H
    Keating, M
    BLOOD, 1997, 90 (10) : 1851 - 1851
  • [8] The expression of cellular retinoid binding proteins in non-APL leukemic cells and its association with retinoid sensitivity
    Lehmann, S
    Paul, C
    Törmä, H
    LEUKEMIA & LYMPHOMA, 2002, 43 (04) : 851 - 858
  • [9] Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL))
    Kueley-Bagheri, Yasemin
    Kreuzer, Karl-Anton
    Monsef, Ina
    Luebbert, Michael
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):
  • [10] Screening for retinoic acid receptor alpha (RARα) rearrangements in non-APL identifies a novel fusion gene in CMML
    Padua, RA
    Parrado, A
    Jordan, D
    Bastard, C
    McKenna, S
    Whittaker, J
    Bentley, P
    Burnett, A
    Chomienne, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 33 - 33
12345